Independent data presented at society for surgical oncology conference demonstrated decisiondx®-melanoma outperforms t-stage at identifying patients with low risk of sentinel lymph node positivity

Friendswood, texas--(business wire)---- $cstl #cstl--castle will share new data on decisiondx®-melanoma and i31-slnb at the sso 2022 international conference on surgical cancer care, march 9-12.

CSTL Ratings Summary

CSTL Quant Ranking